CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2019, Vol. 37 ›› Issue (2): 218-222.doi: 10.12140/j.issn.1000-7423.2019.02.018
• REVIEWS • Previous Articles Next Articles
Xin LIU1(), Yong-fen QI1,2, Yan-rong YU1,*(
)
Received:
2018-08-29
Online:
2019-04-30
Published:
2019-05-13
Contact:
Yan-rong YU
E-mail:liuxin0509@foxmail.com;yuyr@bjmu.edu.cn
Supported by:
CLC Number:
Xin LIU, Yong-fen QI, Yan-rong YU. Effects of soluble egg antigens on hepatic stellate cells in the progression of schistosomiasis-associated liver fibrosis[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2019, 37(2): 218-222.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jsczz.cn/EN/10.12140/j.issn.1000-7423.2019.02.018
[1] | Rollinson D, Knopp S, Levitz S, et al. Time to set the agenda for schistosomiasis elimination[J]. Acta Trop, 2013, 128(2): 423-440. |
[2] | 金嘉宁, 党辉, 张利娟, 等. 2016年全国血吸虫病监测点疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2017(6): 542-548. |
[3] | 关周, 吕山, 李石柱, 等. 我国流动人口血吸虫病流行现状及防控挑战[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(6): 598-603. |
[4] | Lenna S, Trojanowska M.The role of endoplasmic reticulum stress and the unfolded protein response in fibrosis[J]. Curr Opin Rheumato, 2012, 24(6): 663-668. |
[5] | Colley DG, Bustinduy AL, Secor WE, et al. Human schistosomiasis[J]. Lancet, 2014, 383(9936): 2253-2264. |
[6] | Colley DG, Secor WE.Immunology of human schistosomiasis[J]. Parasite Immuno, 2014, 36(8): 347-357. |
[7] | Karsdal MA, Manon-Jensen T, Genovese F, et al. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 308(10): G807-830. |
[8] | Higashi T, Friedman SL, Hoshida Y.Hepatic stellate cells as key target in liver fibrosis[J]. Adv Drug Deliv Rev, 2017, 121: 27-42. |
[9] | Huang Y, Huang D, Weng J, et al. Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells[J]. Mol Cell Biochem, 2016, 423(1-2): 9-20. |
[10] | Ellis EL, Mann DA.Clinical evidence for the regression of liver fibrosis[J]. J Hepatol, 2012, 56(5): 1171-1180. |
[11] | Friedman SL.Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver[J]. Physiol Rev, 2008, 88(1): 125-172. |
[12] | Hong F, Tuyama A, Lee TF, et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation[J]. Hepatology, 2009, 49(6): 2055-2067. |
[13] | Seki E, De Minicis S, Gwak GY, et al. CCR1 and CCR5 promote hepatic fibrosis in mice[J]. J Clin Invest, 2009, 119(7): 1858-1870. |
[14] | Liang YJ, Luo J, Lu Q, et al. Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells[J]. PLoS One, 2012, 7(8): e42490. |
[15] | Nakatsumi H, Matsumoto M, Nakayama KI.Noncanonical pathway for regulation of CCL2 expression by an mTORC1-FOXK1 axis promotes recruitment of tumor-associated Macrophages[J]. Cell Rep, 2017, 21(9): 2471-2486. |
[16] | Xing Y, Tian Y, Kurosawa T, et al. CCL11-induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis[J]. Genes Cells, 2016, 21(6): 624-638. |
[17] | Zhang YL, Han DH, Kim DY, et al. Role of interleukin-17A on the chemotactic responses to CCL7 in a murine allergic rhinitis model[J]. PLoS One, 2017, 12(1): e0169353. |
[18] | He X, Pu G, Tang R, et al. Activation of NF-κB in the hepatic stellate cells of mice with Schistosomiasis japonica[J]. PLoS One, 2014, 9(8): e104323. |
[19] | Zhang S, Wang Z, Zhu J, et al. Carnosic acid alleviates BDL-induced liver fibrosis through miR-29b-3p-mediated inhibition of the high-mobility group box 1/Toll-like receptor 4 signaling pathway in rats[J]. Front Pharmacol, 2017, 8: 976. |
[20] | Wen Z, Ji X, Tang J, et al. Positive feedback regulation between transglutaminase 2 and Toll-like receptor 4 signaling in hepatic stellate cells correlates with liver fibrosis post Schistosoma japonicum infection[J]. Front Immunol, 2017, 8: 1808. |
[21] | Wang W, Xiao F, Wan P, et al. EV71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex[J]. PLoS Pathog, 2017, 13(1): e1006123. |
[22] | Wree A, Eguchi A, McGeough MD, et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice[J]. Hepatology, 2014, 59(3): 898-910. |
[23] | Heindryckx F, Binet F, Ponticos M, et al. Endoplasmic reticulum stress enhances fibrosis through IRE1a-mediated degradation of miR-150 and XBP-1 splicing[J]. EMBO Mol Med, 2016, 8(7): 729-744. |
[24] | Mridha AR, Wree A, Robertson AAB, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice[J]. J Hepatol, 2017, 66(5): 1037-1046. |
[25] | 温镇成, 季小芳, 林桂莹, 等. 肝组织中NLRP3炎症小体活化与日本血吸虫感染小鼠肝纤维化程度的相关性[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(4): 322-326. |
[26] | Meng N, Xia M, Lu Y Q, et al. Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection[J]. Oncotarget, 2016, 7(26): 39316-39331. |
[27] | Lu YQ, Zhong S, Meng N, et al. NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with Schistosoma japonicum in a syk-dependent manner[J]. Sci Rep, 2017, 7(1): 8120. |
[28] | Gao WY, Li D, Cai DE, et al. Hepatitis B virus X protein sensitizes HL-7702 cells to oxidative stress-induced apoptosis through modulation of the mitochondrial permeability transition pore[J]. Oncol Rep, 2017, 37(1): 48-56. |
[29] | Cao Z, Fang Y, Lu Y, et al. Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome[J]. J Pineal Res, 2017, 62(3). |
[30] | Wang Y, Zhang Z, Wang X, et al. Amelioration of ethanol-induced hepatitis by magnesium Isoglycyrrhizinate through inhibition of neutrophil cell infiltration and oxidative damage[J]. Mediators Inflamm, 2017, 2017: 3526903. |
[31] | Mello T, Zanieri F, Ceni E, et al. Oxidative stress in the healthy and wounded hepatocyte: a cellular organelles perspective[J]. Oxid Med Cell Longev, 2016, 2016: 8327410. |
[32] | Luangmonkong T, Suriguga S, Mutsaers HAM, et al. Targeting oxidative stress for the treatment of liver fibrosis[J]. Rev Physiol Biochem Pharmacol, 2018, 175: 71-102. |
[33] | Crosas-Molist E, Fabregat I.Role of NADPH oxidases in the redox biology of liver fibrosis[J]. Redox Biol, 2015, 6: 106-111. |
[34] | He P, Wu Y, Shun J, et al. Baicalin ameliorates liver injury induced by chronic plus binge ethanol feeding by modulating oxidative stress and inflammation via CYP2E1 and NRF2 in mice [J]. Oxid Med Cell Longev, 2017, 2017: 4820414. |
[35] | Ma J, Li M, Kalavagunta PK, et al. Protective effects of cichoric acid on H2O2-induced oxidative injury in hepatocytes and larval zebrafish models[J]. Biomed Pharmacother, 2018, 104: 679-685. |
[36] | Lu C, Zou Y, Liu Y, et al. Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system[J]. Toxicol Appl Pharmacol, 2017, 318: 69-78. |
[37] | Wang M, Abais JM, Meng N, et al. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase[J]. Free Radic Biol Med, 2014, 71: 109-120. |
[38] | Wang Q, Chou X, Guan F, et al. Enhanced Wnt signalling in hepatocytes is associated with Schistosoma japonicum infection and contributes to liver fibrosis[J]. Sci Rep, 2017, 7(1): 230. |
[39] | Sun X, Zhang L, Wang J, et al. Schistosoma japonicum protein SjP40 inhibits TGF-β1-induced activation of hepatic stellate cells[J]. Parasitol Res, 2015, 114(11): 4251-4257. |
[40] | McHugh D, Gil J. Senescence and aging: Causes, consequences, and therapeutic avenues[J]. J Cell Biol, 2018, 217(1): 65-77. |
[41] | Zhang J, Wang M, Zhang Z, et al. Celecoxib derivative OSU-03012 inhibits the proliferation and activation of hepatic stellate cells by inducing cell senescence[J]. Mol Med Rep, 2015, 11(4): 3021. |
[42] | Chen J, Xu T, Zhu D, et al. Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway[J]. Cell Death Dis, 2016, 7(7): e2315. |
[43] | Xu T, Chen J, Zhu D, et al. Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells via SKP2/P27 signaling pathway[J]. Sci Rep, 2017, 7(1): 275. |
[44] | Yang X, Feng L, Zhang Y, et al. Cytotoxicity induced by fine particulate matter (PM2.5) via mitochondria-mediated apoptosis pathway in human cardiomyocytes[J]. Ecotoxicol Environ Saf, 2018, 161: 198-207. |
[45] | Illanes SE, Maisey K, Sandoval M, et al. Fas ligand(+) fallopian tube epithelium induces apoptosis in both Fas receptor(+) T lymphocytes and endometrial cells[J]. Fertil Steril, 2013, 100(2): 550-560 e3. |
[46] | Luo T, Zhang H, Yu Q, et al. ERK1/2 MAPK promotes autophagy to suppress ER stress-mediated apoptosis induced by cadmium in rat proximal tubular cells[J]. Toxicol In Vitro, 2018, 52: 60-69. |
[47] | Duan Y, Gu X, Zhu D, et al. Schistosoma japonicum soluble egg antigens induce apoptosis and inhibit activation of hepatic stellate cells: a possible molecular mechanism[J]. Int J Parasitol, 2014, 44(3-4): 217-224. |
[48] | Wang J, Xu F, Zhu D, et al. Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression[J]. PLoS Negl Trop Dis, 2014, 8(8): e3106. |
[1] | CAO Deping, LI Jiajing, SONG Mengwei, MO Gang. Experimental observation on the changes of hepatic stellate cells stimulated in vitro with tissue protein of Echinococcus multilocularis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(4): 440-445. |
[2] | LI Jie, WEN Yusong, LI Zhaojun. Effect of tourism development on schistosomiasis control in China [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(3): 355-360. |
[3] | CHEN Lin, ZHU Jifeng, QIU Jingfan, XU Zhipeng, ZHANG Donghui, CHEN Lu, HE Jian, LI Wei, YANG Kun, JI Minjun. Design and development of a virtual simulation project for schistosomiasis control based on the One Health concept [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(1): 81-84. |
[4] | JIANG Xiao-feng, SHEN Yu-juan. Research progress on liver fibrosis caused by Echinococcus infection [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(5): 656-660. |
[5] | FENG Jia-xin, GONG Yan-feng, LUO Zhuo-wei, WANG Wei, CAO Chun-li, XU Jing, LI Shi-zhu. Scientific basis of strategies for schistosomiasis control and prospect of the 14th Five-Year Plan in China [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(4): 428-435. |
[6] | CHEN Bing, ZHANG Guo-li, ZHANG Gao-hong. Research progress on clinical trials of schistosomiasis vaccine candidates [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(4): 511-515. |
[7] | GAO Yuan, HU Yuan, CAO Jian-ping. Research progress on the role of immune cells in liver fibrosis due to schistosomiasis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(1): 88-93. |
[8] | GUO Su-ying, ZHU Hong-qing, CAO Chun-li, DENG Wang-ping, BAO Zi-ping, JIA Tie-wu, LI Yin-long, LV Chao, QIN Zhi-qiang, ZHANG Li-juan, FENG Ting, YANG Fan, LV Shan, XU Jing, LI Shi-zhu. Risk assessment of schistosomiasis transmission along the middle and lower reaches of Yangtze River after flooding in 2020 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(6): 753-758. |
[9] | SHI Liang, XIONG Chun-rong, LIU Mao-mao, WEI Xiu-shen, ZHANG Jian-feng, WANG Xin-yao, WANG Tao, HANG De-rong, YANG Hai-tao, YANG Kun. Evaluation of efficacy of visual intelligent recognition model for Oncomelania hupensis based on deep learning technology [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(6): 764-770. |
[10] | LI Bo, ZHANG Cong, SHAN Xiao-wei, YI Jia, TU Zhen, HE Hui, TANG Li, ZHU Hong, LIU Jian-bing. Evaluation of the pathogen detection capacity in standardized schistosomiasis laboratories in Hubei Province [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 572-576. |
[11] | WU Jia-li, LI Bo, LIU Si, TU Zu-wu, TANG Li, TU Zhen, ZHOU Xiao-rong, SUN Ling-cong, XIAO Ying, ZHU Hong. Assessment of transmission risk of human schistosomiasis japonica based on human population antibody level in Hubei Province [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 578-584. |
[12] | HU Fei, GAO Zhu-lu, YUAN Min, LI Zhao-jun, LI Yi-feng, LIU Yue-min, LI Jian-ying, XIE Shu-ying, WEN Yu-song, LIN Dan-dan. Changing trends of schistosome infection and liver fibrosis among residents in the Poyang Lake region [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 629-636. |
[13] | LIU Rong, ZHANG Jian-feng, YAN Xiao-lan, WEN Li-yong. Comparative study of SF-36 and EQ-5D-5L in evaluating quality of life for patients with advanced schistosomiasis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 639-645. |
[14] | LIU Rong, WEN Li-yong. New progress in basic and clinical research of advanced schistosomiasis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(4): 429-436. |
[15] | HONG Zhong, WU Ling-ling, WANG Li-ping, XU Jing. Progress and challenges on global schistosomiasis control [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(4): 514-519. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||